Impact of Vertigoheel® on Patients Suffering From Bilateral Vestibulopathy and Functional Dizziness

Inclusion Criteria

• •Treatment with Vertigoheel® has been chosen by the physician independently of including the patient in this non-interventional study.
• •Bilateral vestibulopathy or functional dizziness according to the current diagnostic criteria of the Bárány Society
• •Symptoms for \> 3 months of moderate to severe intensity according to the dizziness handicap inventory \[0 (minimum score) -100 (maximum score)\] between 30 to 90 points.
• •≥18 years of age
• •Legally competent male or female outpatient.
• •Signed informed consent.
• •Not pregnant (as proven by negative pregnancy test in case of woman of childbearing potential before first study drug administration) or breast-feeding.